ARCHIVES

Dana-Farber Correction Plan Sent To State; Pharmacy Chief Resigns

This article is from The Cancer Letter archive.

Vol. 21 No. 23 | June 9, 1995

Download PDF Visit The Full Archive

Related Articles

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

December 17, 2013

ACS Urges Bush To Increase NCI Budget.

January 19, 2007

US, Italy Plan Greater Scientific Collaboration

May 16, 2003

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006

NCI Advisors: Resume Prevention Trial, Add Edometrial Sampling

May 13, 1994

In Brief: Senate Committee Cuts House Amount For NCI; NCI Staff Faces Up to 22 Days Unpaid Leave

September 21, 1990